Phil Franchina, Author at American Parkinson Disease Association

Recently published results of a GDNF intraputaminal infusion clinical trial

Posted on March 5, 2019 by Phil Franchina

A clinical trial, is by definition an experiment or a test — an effort to determine if something works,...see more or doesn’t. Sometimes, although the intended outcome of a clinical trial may fall short of expectations, the results are nevertheless intriguing and may spark additional avenues of investigation. Such is the case in a clinical trial […]

What’s Happening at APDA

Posted on February 6, 2019February 6, 2019 by Phil Franchina

What's Happening at APDA

Ask The Doctor – Q & A

Posted on February 6, 2019February 6, 2019 by Phil Franchina

Ask The Doctor – Q & A Q. What is the maximum dose of Carbidopa/Levodopa that can be used...see more for PD? A. Carbidopa/levodopa doses vary significantly. The range can be from 300 mg/day to up to as much as 3,000 mg/day. To determine the right dose for you, you and your physician should discuss: What […]

Research Update

Posted on February 6, 2019February 6, 2019 by Phil Franchina

Deep brain stimulation may slow the progression of tremor if performed in early PD.

New Resource: My Mommy Has PD…But It’s Okay! Booklet

Posted on February 6, 2019April 19, 2024 by Phil Franchina

When telling people about your PD diagnosis, each conversation can bring...see more its own challenges.

Profile: Christine from Look Closer Campaign

Posted on February 6, 2019February 12, 2019 by Phil Franchina

Look Closer: Meet Christine Christine’s determination and outgoing nature are obvious to everyone, and they make her a pillar of...see more strength for her friends and for her family, including her five children.

Centers for Advanced Research: Spotlight on Mayo Clinic

Posted on February 6, 2019September 4, 2024 by Phil Franchina

, Jacksonville, Florida Your support helps APDA fund eight Centers for Advanced Research...see more across the United States, where some of the best scientists in the field are conducting cutting-edge investigations that are helping us understand what causes PD and how best to treat it, and ultimately getting us closer to a cure.

Spotlight on Dr. Giulietta Riboldi

Posted on February 5, 2019February 13, 2019 by Phil Franchina

Spotlight on Dr. Giulietta Roboldi Giulietta Riboldi, PhD, a post-doctoral fellow at the Marlene and Paolo Fresco Institute for Parkinson’s...see more disease and Movement Disorders at NYU Langone Health, is the recipient of a 2018 APDA Post-Doctoral Fellowship for her work studying how mutations in a protein called glucocerebrosidase (GBA) mutations lead to the development Parkinson’s disease (PD).

Marijuana & PD

Posted on February 5, 2019April 2, 2019 by Phil Franchina

Marijuana & PD While the medications that doctors prescribe for PD can be helpful, there remain gaps in what the...see more medications can treat. Some people with PD are eager to find alternative methods to help their symptoms and look into whether other therapies, such as medical marijuana, also known as medical cannabis, can be useful.

FDA Approves Inbrija™ (levodopa inhalation powder) Parkinson’s disease

Posted on December 23, 2018December 26, 2018 by Phil Franchina

FDA Approves Inbrija™ (levodopa inhalation powder) December 22, 2018 Acorda Therapeutics announced the FDA approval of INBRIJA™ (levodopa inhalation powder)...see more for the treatment of OFF periods in people with Parkinson’s disease (PD) taking carbidopa/levodopa. INBRIJA™ is expected to be available by prescription in the first quarter of 2019, to be distributed through a network of specialty […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Recently published results of a GDNF intraputaminal infusion clinical trial

What’s Happening at APDA

Ask The Doctor – Q & A

Research Update

New Resource: My Mommy Has PD…But It’s Okay! Booklet

Profile: Christine from Look Closer Campaign

Centers for Advanced Research: Spotlight on Mayo Clinic

Spotlight on Dr. Giulietta Riboldi

Marijuana & PD

FDA Approves Inbrija™ (levodopa inhalation powder) Parkinson’s disease

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!